Spots Global Cancer Trial Database for Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96
Official Title: Immunotherapy of Gastric Cancer With Autologous Tumor Derived Heat Shock Protein gp96
Study ID: NCT02317471
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the safety and effectiveness of autologous gp96 treatment of gastric cancer.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chinese PLA General Hospital, Beijing, Beijing, China
Contact Details
Name: Lin Chen, MD
Affiliation: Chinese PLA General Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
